Some people are scared of weight loss medications because of a different weight loss drug fenfluramine that was found to be dangerous and pulled off the market in 1997
Fifth, other studies have reported high one-year discontinuation rates (64.8% in non-T2DM and 46.5% in T2DM cohorts) and low 1-year re-initiation rates of GLP-1RA (36.3% in non-T2DM and 47.3% in T2DM cohorts), largely contributed by moderate or severe incident gastrointestinal adverse events and lower income status [107,108,109,110,111]
Semaglutide (Wegovy) works by targeting one receptor to help control appetite and blood sugar, while Tirzepatide (Mounjaro) targets two receptors, which can lead to potentially greater weight loss results in some patients
Dangers GHB is a powerful depressant and the dangers of a GHB overdose come from this strong depression of vital functions
Sermorelin has previously fda-approved